In cancer, tumor cells often express programmed death-ligand 1 (PD-L1) to bind to their receptor the programmed cell death-1 (PD-1) in the tumor-infiltrating lymphocytes (TILs) to suppress their antitumor actions [1]. The gene discussed is PDCD1; the disease is neoplasm.